ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,782Medicare Part D Prescriptions Filled, Including Refills

Rank: 290 out of 972

$486K Total Retail Price of All Prescriptions

Rank: 336 out of 972

745 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 745 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 745 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,883 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 473 414 1 2
LISINOPRIL 411 315 2 1
CARVEDILOL 300 287 3 21
HYDROCODONE-ACETAMINOPHEN 297 238 S3 4 6
FUROSEMIDE 294 245 5 7
LEVOTHYROXINE SODIUM 286 264 6 3
AMLODIPINE BESYLATE 246 236 7 4
POTASSIUM CHLORIDE 240 186 8 13
CITALOPRAM HBR 232 193 9 19
OMEPRAZOLE 231 176 10 5
METFORMIN HCL 179 134 11 8
WARFARIN SODIUM 170 169 12 12
GABAPENTIN 166 119 13 14
MELOXICAM 163 100 14 36
METOPROLOL TARTRATE 161 127 15 9
METOPROLOL SUCCINATE 148 145 16 16
GLIMEPIRIDE 144 126 17 34
HYDROCHLOROTHIAZIDE 141 131 18 10
PRAVASTATIN SODIUM 136 111 19 20
ATORVASTATIN CALCIUM 131 105 20 11
LANTUS SOLOSTAR 100 69 21 86
ZOLPIDEM TARTRATE 98 76 22 23
ISOSORBIDE MONONITRATE ER 98 85 22 43
ALLOPURINOL 95 95 24 28
PANTOPRAZOLE SODIUM 93 86 25 41
CLOPIDOGREL 89 78 26 37
CRESTOR 84 59 27 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 63 28 32
JANUVIA 80 70 29 75
AZITHROMYCIN 77 60 30 42
DIOVAN 76 76 31 48
AMITRIPTYLINE HCL 72 68 R 32 58
PEN NEEDLE 71 61 33 99
DONEPEZIL HCL 70 67 34 26
SPIRIVA 69 58 35 56
LOVASTATIN 67 60 36 22
METFORMIN HCL ER 66 40 37 62
TRAMADOL HCL 66 53 37 15
NEXIUM 65 49 39 30
NAMENDA 65 61 39 38
METHYLPREDNISOLONE 64 45 41 119
DIGOXIN 64 64 41 52
ALENDRONATE SODIUM 61 61 43 27
PAROXETINE HCL 54 38 44 64
PLAVIX 53 44 45 55
CLONIDINE HCL 53 45 45 57
LOSARTAN-HYDROCHLOROTHIAZIDE 52 26 47 61
LOSARTAN POTASSIUM 52 52 47 17
POLYETHYLENE GLYCOL 3350 51 40 49 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.